Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston boosts share in brain monitoring company:

This article was originally published in Clinica

Executive Summary

Boston Scientific has spent $8.1m on acquiring a further 500,000 shares of common stock in Aspect Medical Systems. The two companies had formed a strategic alliance in August 2002 to introduce New York-based Aspect's sedation management technology to new markets. Under this agreement, Boston bought 1.43 million shares of Aspect's stock and provided the New York-based developer of brain monitoring systems with a $5m revolving line of credit. The contract stipulated that Boston could acquire up to 25% of Aspect's outstanding common stock in the market. This recent purchase pushes the Natick, Massachusetts-based company's share of Aspect to 22.5%.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel